SPEC — SpectraCure AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK254.48m
- SEK204.25m
- SEK2.84m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.96 | ||
| Price to Tang. Book | 4.95 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 89.51 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.9% | ||
| Return on Equity | -14.59% | ||
| Operating Margin | -751% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 3.25 | 5.1 | 5.74 | 2.94 | 2.84 | n/a | n/a | 28.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SpectraCure AB (publ) is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in cancer treatment technology. The Company develops photodynamic therapeutics based on photosensitive materials activated by laser. The Company's method is called interstitial photodynamic therapy (PDT). Interstitial PDT can be used for solid tumors in internal organs, such as cancer in the prostate, pancreas, and the head and neck area, among others. In addition, the Company offers software platform IDOSE for interstitial PDT treatment of solid cancer tumors in internal organs. With SpectraCure’s interstitial PDT method, the patient is given a photoactivated drug - photosensitizer in combination with laser light guided by a dose control system.
Directors
- Ingemar Kihlstrom CHM (67)
- Johan Folkunger CEO
- Henrik Ljung CFO (63)
- Johannes Swartling CTO
- Annika Andersson OTH
- Johan Glindre OTH
- Johan Ingemansson OTH
- Ulf Bladin DRC
- Masoud Khayyami DRC (58)
- Hans Bornefalk IND
- Katarina Svanberg IND
- Sune Svanberg IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 20th, 2003
- Public Since
- July 1st, 2015
- No. of Employees
- 15
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 97,131,608
- Address
- Gasverksgatan 1, LUND, 222 29
- Web
- https://spectracure.com/
- Phone
- +46 462863770
- Contact
- Kristina Hallstrom
- Auditors
- KPMG AB
Upcoming Events for SPEC
Similar to SPEC
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the SpectraCure AB (publ) share price?
As of Today at 19:20 UTC, shares in SpectraCure AB (publ) are trading at SEK2.62. This share price information is delayed by 15 minutes.
How has the SpectraCure AB (publ) share price performed this year?
Shares in SpectraCure AB (publ) last closed at SEK2.62 and the price had moved by -42.48% over the past 365 days. In terms of relative price strength the SpectraCure AB (publ) share price has underperformed the FTSE Global All Cap Index by -46% over the past year.
What are the analyst and broker recommendations for SpectraCure AB (publ)?
There is no consensus recommendation for this security.
What is the SpectraCure AB (publ) dividend yield?
SpectraCure AB (publ) does not currently pay a dividend.
Does SpectraCure AB (publ) pay a dividend?
SpectraCure AB (publ) does not currently pay a dividend.
When does SpectraCure AB (publ) next pay dividends?
SpectraCure AB (publ) does not currently pay a dividend.
How do I buy SpectraCure AB (publ) shares?
To buy shares in SpectraCure AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SpectraCure AB (publ)?
As of the previous close price of SEK2.62, shares in SpectraCure AB (publ) had a market capitalisation of SEK254.48m.
Where are SpectraCure AB (publ) shares listed?
Here are the trading details for SpectraCure AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: SPEC
What kind of share is SpectraCure AB (publ)?
Based on an overall assessment of its quality, value and momentum SpectraCure AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SpectraCure AB (publ) share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the SpectraCure AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SpectraCure AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -32.77%.
As of the last closing price of SEK2.62, shares in SpectraCure AB (publ) were trading -32.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SpectraCure AB (publ) PE Ratio?
The SpectraCure AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SpectraCure AB (publ)?
SpectraCure AB (publ)'s management team is headed by:
- Ingemar Kihlstrom - CHM
- Johan Folkunger - CEO
- Henrik Ljung - CFO
- Johannes Swartling - CTO
- Annika Andersson - OTH
- Johan Glindre - OTH
- Johan Ingemansson - OTH
- Ulf Bladin - DRC
- Masoud Khayyami - DRC
- Hans Bornefalk - IND
- Katarina Svanberg - IND
- Sune Svanberg - IND